Trastuzumab Deruxtecan in Previously Treated HER2-Low Metastatic Breast Cancer: Real-World Multicentric Study in the Portuguese Population.
- DOI
- 10.3390/cancers17121911
- Published
- 2025-06-09
- Container
- Cancers (Basel)
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.3390/cancers17121911,
title = {Trastuzumab Deruxtecan in Previously Treated HER2-Low Metastatic Breast Cancer: Real-World Multicentric Study in the Portuguese Population.},
author = {Soares Miranda L and Sousa MJ and Martins Braga M and Couto M and Vieira Fernandes I and Abreu F and Eiriz I and Lopes Fernandes C and Fonseca Marques A and Marques MT and Romão R and Gonçalves F and Simões J and Araújo A.},
year = {2025},
journal = {Cancers (Basel)},
doi = {10.3390/cancers17121911},
url = {https://doi.org/10.3390/cancers17121911}
}RIS
TY - JOUR TI - Trastuzumab Deruxtecan in Previously Treated HER2-Low Metastatic Breast Cancer: Real-World Multicentric Study in the Portuguese Population. AU - Soares Miranda L AU - Sousa MJ AU - Martins Braga M AU - Couto M AU - Vieira Fernandes I AU - Abreu F AU - Eiriz I AU - Lopes Fernandes C AU - Fonseca Marques A AU - Marques MT AU - Romão R AU - Gonçalves F AU - Simões J AU - Araújo A. PY - 2025 JO - Cancers (Basel) DO - 10.3390/cancers17121911 UR - https://doi.org/10.3390/cancers17121911 ER -
APA
L, S. M., MJ, S., M, M. B., M, C., I, V. F., F, A., I, E., C, L. F., A, F. M., MT, M., R, R., F, G., J, S., & A., A. (2025). Trastuzumab Deruxtecan in Previously Treated HER2-Low Metastatic Breast Cancer: Real-World Multicentric Study in the Portuguese Population.. Cancers (Basel). https://doi.org/10.3390/cancers17121911
Source records
- europe-pmc · retrieved 2026-09-27T05:39:38.905Z